Alteco Medical AB avnoteras från Spotlight Stock Market / Alteco Medical AB is delisted from Spotlight Stock Market

Report this content

(for English version, please see below) 

Spotlight Stock Market har efter ansökan från Alteco AB (Bolaget) beslutat att avnotera Bolagets aktie ALTE. Sista dag för handel i Bolagets aktie är den 12 februari 2025.  

Bolaget offentliggjorde den 29 januari 2025 pressmeddelandet “Alteco Medical AB avnoteras från Spotlight Stock Market”. 

Eftersom Anders Althin med bolag kontrollerar mer än 90 procent av samtliga aktier och röster samt har meddelat avsikten att påkalla inlösenförfarande av resterande aktier i Bolaget har Spotlight Stock Market beviljat Bolagets ansökan om avnotering och därmed beslutat att avnotera Bolagets aktier från Spotlight Stock Market.  

Alteco Medical AB is delisted from Spotlight Stock Market 

Spotlight Stock Market has due to a request from Alteco Medical AB decided to delist the company’s share ALTE. Last day of trading in the company’s share ALTE will be February 12, 2025. 

On January 29, 2025, the company disclosed the press release ”Alteco Medical AB avnoteras från Spotlight Stock Market”. 

Since Anders Althin controls more than 90 percent of all outstanding shares and votes and intends to initiate compulsory acquisition procedure for the remaining shares, Spotlight Stock Market has decided to delist the company’s shares.  

Spotlight Stock Market  
+46 8-51168000   
E-mail: issuer@spotlightstockmarket.com   

About Spotlight  

Spotlight Stock Market is a market place that wants to make it easier, safer and more visible for growth companies to become and be listed. The company also offers investors the opportunity to become shareholders in growth companies in an easier and safer way. At Spotlight Stock Market there are more than 140 listed growth companies from different industries, as well as over 40 ETP:s. Spotlight Stock Market was founded in 1997, has 20 employees and the head office in Stockholm. Read more at www.spotlightstockmarket.com 

Prenumerera

Dokument & länkar